Neoplasm
RecruitingLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
France- Participants:18–64 years · 65+ years
- Substances:Adagrasib
- Sponsor:Bristol-Myers Squibb Services Unlimited Company
Rare diseases
Investigational molecules
Locations
Back to France45 clinical trials in Villefranche sur Saône, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple trials exploring innovative treatment strategies for both early-stage and metastatic disease.
Studies investigating treatments for colorectal cancer and gastroesophageal cancers, with particular focus on targeted therapies and combination approaches.
Research emphasizing personalized treatment approaches based on specific genetic mutations.
Diverse research portfolio including studies on nephrotic syndrome and severe asthma, evaluating new treatment protocols and medication management strategies.
Focus on improving patient outcomes through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.